Facebook Twitter Google+ LinkedIn Youtube Follow us on:
02/12/2015 :
Manufacturing authorization of gene therapy medicinal products granted to CELLforCURE, the LFB group subsidiary specialized in innovative therapies
Read all
02/05/2015 :
SIPPET Study on inhibitors in Hemophilia A: interim analysis confirms the original hypothesis
Read all
12/18/2014 :
LFB S.A. Announces Achievement of Patient Enrollment Target for PerSept 1 Program for the Evaluation of Recombinant Factor Seven Efficacy by Prospective Clinical Trials
Read all
LFB Group Web Sites